Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Resolution of chronic synovitis with Emicizumab?
Emicizumab continues to reshape our understanding of joint outcomes in severe Hemophilia A — transforming not only bleeding prevention, but also long‑term joint health.
At EAHAD2026, this poster by Matteo Di Minno, using HEAD‑US and HJHS in 52 adults on long‑term Emicizumab prophylaxis showed:
- Significant improvement in hypertrophic synovium scores over ≥2 years
- >50% of joints with hypertrophic synovium at baseline showed reduction or resolution
- Very few de‑novo HS findings in previously unaffected joints, suggesting structural joint protection in routine practice
Interestingly, joints with pre‑existing degenerative changes improved the least – a strong reminder that timing of effective prophylaxis still matters.
It will be particularly interesting to see how these real‑world imaging data will align with the ongoing Phase IV Beyond ABR study (NCT05181618), which is exploring broader health and joint outcomes under Emicizumab.”
Find more posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Jul 3, 2026, 05:55New Evidence Supports Chromogenic Assays After Hemophilia A Gene Therapy – JTH
-
Jul 3, 2026, 05:50Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
-
Jul 3, 2026, 05:25Brian A Beh: A New Approach from The George Institute for Global Health Could Transform Stroke Care Before Hospital Arrival
-
Jul 3, 2026, 05:22Deirdre Finnigan: New Insights into Red Blood Cell Biomechanics in Cancer-Associated Anemia
-
Jul 3, 2026, 05:15Danielle Boyle: Collaboration Across Borders Is Helping Shape the Future of ITP Care
-
Jul 3, 2026, 05:05Claire McIvor: One Year at the Stroke Association and Grateful for a Workplace That Made It Possible
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026
-
Jul 2, 2026, 21:54Rob Maloney: Rare Disease Requires Relational Care
-
Jul 2, 2026, 21:53Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy